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Abstract
GABA type-A receptors are essential for fast inhibitory neurotransmission and are critical in brain function. Surprisingly,
expression of receptor subunits is highly variable among individuals, but the cause and impact of this fluctuation remains
unknown. We have studied sources of variation for all 19 receptor subunits using massive expression data sets collected
across multiple brain regions and platforms in mice and humans. Expression of Gabra1, Gabra2, Gabrb2, Gabrb3, and Gabrg2
is highly variable and heritable among the large cohort of BXD strains derived from crosses of fully sequenced parents—
C57BL/6J and DBA/2J. Genetic control of these subunits is complex and highly dependent on tissue and mRNA region.
Remarkably, this high variation is generally not linked to phenotypic differences. The single exception is Gabrb3, a locus that
is linked to anxiety. We identified upstream genetic loci that influence subunit expression, including three unlinked regions
of chromosome 5 that modulate the expression of nine subunits in hippocampus, and that are also associated with multiple
phenotypes. Candidate genes within these loci include, Naaa, Nos1, and Zkscan1. We confirmed a high level of coexpression
for subunits comprising the major channel—Gabra1, Gabrb2, and Gabrg2—and identified conserved members of this
expression network in mice and humans. Gucy1a3, Gucy1b3, and Lis1 are novel and conserved associates of multiple
subunits that are involved in inhibitory signaling. Finally, proximal and distal regions of the 39 UTRs of single subunits have
remarkably independent expression patterns in both species. However, corresponding regions of different subunits often
show congruent genetic control and coexpression (proximal-to-proximal or distal-to-distal), even in the absence of
sequence homology. Our findings identify novel sources of variation that modulate subunit expression and highlight the
extraordinary capacity of biological networks to buffer 4–100 fold differences in mRNA levels.
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Introduction
There is an extraordinarily high level of variation in expression of
messenger RNAs of key inhibitory GABA type-A receptors
(GABA(A)R) in human brain. For example, GABRA1—a key
constituent of the great majority of functional receptors—varies
over a 100-foldrange intheneocortexof a sampleof187healthybut
elderlyhumans [1].In comparison,inthesamesample,theGABRG2
and GABRB1 receptors ‘‘only’’ vary 10–20 fold. This is a remarkable
range that exceeds that which is often achieved in knock-in and
knock-down experiments in genetically engineered lines of mice.
This variation in expression is doubly remarkable because
dysregulation of GABA(A)R have been linked to a wide range of
abnormalities and neurological diseases, including epilepsy,
autism, impulsivity, substance abuse disorders, mood, psychiatric
disease, and chronic pain. This raises an important question as to
the causes and consequences of the high level of endogenous
variation among normal humans. Is it a technical artifact of array-
based methods? Is it due to difficulties in obtaining high quality
RNA from human brain? Or does it reflect flexible use of
GABA(A)R subunits to assemble pentameric receptors?
To answer these questions we need to weigh the relative
importance of genetic, environmental, and technical sources of
variation. What fraction of variation is heritable and what fraction is
due to environmental or technical error? What is the functional
relevance of these differences at the RNA level? In the large sample
ofhumansstudied byWebsterand colleagues(2009),eachindividual
has a unique genotype and it is not practical to resample the same
genotype many times to estimate or eliminate technical errors.
However, these questions can be addressed efficiently using diverse
sets of fully inbred strains of mice that model human populations.
We have exploited a large set of inbred strains of mice—the
BXD family—to study the expression of GABA(A)R subunits in
the brain. This family is composed of both parent strains (C57BL/
6J and DBA/2J) and ,160 lines. While each line is fully inbred,
the entire collection is highly diverse and members are segregating
for ,5 million sequence variants. Both parents have been fully
sequenced and the progeny have been genotyped at over 7,000
genetic markers. Furthermore, members of this family have been
well phenotyped for ,40 years. This remarkably dense data allows
us to define genetic and phenotypic differences between parents
and among their progeny. As in humans we detect large
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For example, a2, a4, and b3 subunits vary more than 3-fold even
after averaging multiple samples per strain. Here we address four
key questions about the molecular genetics of GABA(A)R subunits:
N What are the sources of variation in subunit mRNA
expression?
N What genomic regions (QTLs), genes, or even sequence
variants contribute to subunit variation?
N To what extent do subunits interact with each other or with
other genes critical in synaptic function at the mRNA level?
N What is the functional impact of this variation in terms of
behavior and disease susceptibility?
Results
Expression, variation, and heritability
We examined expression of GABA(A)R subunits across six
brain regions, two species, and multiple expression platforms using
a large number of probes and probe sets, and RNA sequencing
(RNA-seq). To simplify the presentation much of the analysis is
based on expression in the hippocampus and on data generated
using the Affymetrix M430 and Exon 1.0 ST platforms (Table S1).
Expression values are expressed on a log2 intensity scale. Values of
8 to 9 units correspond to moderate levels of expression (2 to
4 pM), whereas values of 12 to 13 correspond to high levels of
expression (,40 to 80 pM).
A majority of the GABA(A)R subunits are well expressed in the
hippocampus. The most abundant subunits include Gabrb1,
Gabra5, Gabra1, Gabrg2, and Gabrb2. Other subunits are more
moderately expressed (Gabra2, Gabra3, Gabra4, Gabrb3, Gabrg1, and
Gabrd) or expressed at very low levels (Gabrg3). Several subunits,
including Gabra6, Gabrr1, Gabrr2, Gabrr3, Gabre, Gabrp, and Gabrq
are not expressed above background in the hippocampus and are
not considered in detail further. Extensive data is available for all
of these genes and their corresponding probe sets in GeneNetwork
(www.genenetwork.org). As shown in Table 1 and Figure S1, there
is a good correlation between mean subunit expression on the
arrays, gene level expression based on RNA-seq of whole brain,
and the intensity of in situ expression in the Allen Brain Atlas [2].
The expression of a subset of subunits is markedly different
among the BXD strains. For example, the expression level of
Gabra1, Gabra2, Gabra4, Gabrb2, and Gabrb3 differs by more than
2.5-fold among strains (Table 1). This high variation in mRNA
levels is attributable to a combination of technical, environmental,
and genetic factors. Some of the variation could be due to
hybridization artifacts caused by polymorphisms that overlap
probe target sequences [3,4,5]. To eliminate signals resulting from
this artifact we removed probes overlapping SNPs and small indels
(Methods, Table S1). We are confident that the high level of
variation shown in Table 1 is not an artifact. To estimate the
influence of genetic versus environmental modulation we calcu-
lated the heritability of mRNA expression using the large
hippocampal data set (Table S2). For many subunits, heritability
ranged from 0.40 to 0.95—demonstrating that genetic factors are
a major contributor to variation in expression. This heritable
variation enables us to identify genetic loci or so-called expression
quantitative trait loci (eQTLs) that control subunit expression
using genomic extensions of classical gene mapping methods
Table 1. GABA(A)R expression summary.
Symbol
AVG Exon Array/
Probe Sets
AVG FC
Exon Array
AVG M430 Array/
Probe Sets
AVG FC
M430 Array
Allen Brain
Atlas HIP
RNAseq
Gene ID
WB RNAseq
AVG FPKM
WB RNAseq
BXD FC
Gabrr3 7.57/8 4.65 NA NA 0 NM_001081190 0.00 1.00
Gabrd 9.60/11 4.86 9.33/1 2.33 1 NM_008072 13.79 2.93
Gabrr2 7.84/10 3.83 (7.5/1) (1.30) 0 NM_008076 0.06 N/A
Gabrr1 7.60/14 4.33 9.68/2 2.04 0 NM_008075 0.42 3.37
Gabrg1 8.65/14 6.32 7.97/2 2.19 0 NM_010252 3.51 2.34
Gabra2 11.40/18 4.58 10.97/3 4.08 1 NM_008066 10.36 2.79
Gabra4 11.22/14 2.95 10.14/2 2.29 4 NM_010251 11.15 2.80
Gabrb1 12.07/9 2.57 11.83/2 1.57 3 NM_008069 8.33 1.72
Gabrg3 10.26/11 3.29 (7.18/2) (1.52) 1 NM_008074 3.13 2.78
Gabra5 12.03/13 3.34 11.90/1 1.64 5 NM_176942 8.06 2.35
Gabrb3 11.53/7 3.41 10.19/1 3.64 5 NM_001038701 5.19 4.74
Gabrp 6.94/16 5.49 8.58/1 1.37 0 NM_146017 0.01 N/A
Gabrg2 12.55/14 3.07 10.95/2 1.95 3 NM_008073 14.16 3.20
Gabra1 12.75/12 2.37 (12.23/4) (2.13) 4 NM_010250 57.81 2.65
Gabra6 6.95/14 38.69 6.74/2 10.44 0 NM_001099641 14.02 N/A
Gabrb2 12.22/11 2.81 12.14/1 1.53 4 NM_008070 22.50 2.26
Gabre 6.29/14 6.51 7.69/1 1.45 0 NM_017369 0.35 25.93
Gabra3 10.20/18 3.83 8.15/2 2.03 2 NM_008067 12.46 1.97
Gabrq 6.56/13 5.71 6.78/1 1.45 0 NM_020488 0.73 N/A
HIP=Hippocampus, AVG=Average log2 standardized expression with a mean of 8 and standard deviation of 2, Exon=Exon array platform, M430=M430 array
platform, FC=Fold Change in expression between the highest and lowest strain, ()=Measurement includes probes overlapping SNPs as all probe sets are affected,
RNAseq=SOLiD platform RNA sequencing, EXPR=Expression. 0=No expression, 3=Moderate expression, 5=High expression in the hippocampal formation. Gene
ID=NCBI RefSeq ID, FPKM=read fragments per KB gene model per million sample read fragments.
doi:10.1371/journal.pone.0034586.t001
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classified broadly into two types: cis eQTLs and trans eQTLs. A cis
eQTL is caused by sequence variants located within or very close
to the gene from which mRNA is transcribed. In contrast, a trans
eQTL is caused by sequence variants located on a different
chromosome or more than 10 Mb distant from the cognate gene
on the same chromosome.
Modulation by cis eQTLs
In agreement with their high heritability, Gabra1, Gabra2,
Gabrb2, Gabrg2, and Gabrb3 are strongly modulated by cis eQTLs
that have likelihood ratio statistic (LRS) scores above 20 (Figure 1).
(An LRS score can be converted to a logarithm of the odds (LOD)
score by dividing by 4.61; where LOD is approximately equal to
2log(P) of linkage.) Three subunits—Gabra1, Gabrb2, and Gabrg2—
are located close together on chromosome (Chr) 11 between 33
and 42 megabases (Mb) and the remaining two subunits, Gabra2
and Gabrb3, are located within GABA(A)R subunit clusters on Chr
5 (near 71 Mb) and Chr 7 (near 65 Mb), respectively. Higher
expression of all three genes on Chr 11 is generally associated with
the B allele inherited from the maternal C57BL/6J strain whereas
higher expression of Gabra2 and Gabrb3 is always associated with
the D allele inherited from the DBA/2J paternal strain.
We tested the consistency of the cis eQTLs initially detected in
hippocampus from the BXD population at four different levels; (1)
brain tissue, (2) expression platform, (3) mRNA region, and (4)
mouse population.
Comparison of subunit expression across multiple CNS tissues
(whole brain, cerebellum, striatum, cortex, hypothalamus, and
amygdala) and several array platforms in the BXD family reveals
both common as well as unique genetic control of expression of
Gabra1, Gabrb2, Gabrb3, Gabrg2, and Gabra2 (Figure 2). Both Gabra1
and Gabra2 have highly conserved cis-regulation and high LRS
values are always associated with either the B allele (Gabra1)o rD
allele (Gabra2), regardless of brain region or array platform. In
contrast, allelic control of Gabrb2, Gabrb3,a n dGabrg2 is more
complex and varies across tissue and platform (Figure 2). Whole
brain RNA-seq reveals significant expression differences based on
genotype for Gabra2 (fold change=1.9, p=0.05) and Gabra1 (fold
change=19.6, p=0.0002). Higher expression is associated with the
D allele for both subunits. Gabra6, a gene expressed almost
exclusively in the cerebellum, is also cis modulated (higher
expression associated with the D allele) (fold change=4.5,
p=0.0004). We detected no significant difference in expression of
Gabrb2, Gabrg2,o rGabrb3 in our RNA-seq analysis. Cis-regulation of
Gabrg2 by local polymorphisms hasbeenconfirmed by Ciobanu and
colleagues using traditional allele-specific expression assays [4]. For
Gabrg2, higher expression is associated with the D allele (fold
change=1.5, p=4 E-05). Allele-specific expression assays for
Gabra1 failed to confirm a significant expression difference (fold
change=1.03, p=0.09, higher D allele expression). Quantitative
realtime PCR validated the difference in expression for both Gabra1
Figure 1. Summary of significant genetic regulation in the
hippocampus. Probe sets represent columns and ascending genomic
location for each chromosome represent rows. Only chromosomes with
a significant QTL (LRS.15) are shown. Several GABA(A)R subunits are
regulated by both cis and trans eQTL (Gabra1, Gabra2, Gabrb2, and
Gabrb3) whereas some are modified exclusively in trans (Gabra5,
Gabrg1). Hue intensity provides an indication of the strength of the
association between gene expression and genomic location. Red and
blue alleles indicate that the D or B allele increases trait values,
respectively. Arrowheads show the location of each cognate gene.
PC1=first principal component, Chr=Chromosome, Mb=Megabase,
Prox=proximal, mid=middle, dist=distal.
doi:10.1371/journal.pone.0034586.g001
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PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e34586Figure 2. Consistency of cis modulation across tissues. Genetic regulation of the 5 subunits regulated by strong cis eQTLs in the hippocampus
was compared across three different platforms Affymetrix M430 (WB=whole brain, CB=cerebellum), Affymetrix MoGene 1.0 ST (AMY=amgydala
and HYP=hypothalamus), and Illumina (CTX=neocortex, STR=striatum). Each probe set was required to have a mean expression of at least 8 in each
tissue database. Blue and red indicate an association between the B6 and D2 allele at each locus and higher probe set expression, respectively. The
more intense hue indicates a greater association and a corresponding increase in significance. For all data except the HYP and AMY, probes
overlapping SNPs were filtered out and a principal component analysis was performed on remaining probes to capture a component (PC1)
explaining the majority of the variation in probe set expression. Percent of variance explained by each PC1 ranged from (,45% to 95%). Because of
the large number of probes included for measurement in the HYP and AMY, a probe level analysis was not possible. Some probe sets (indicated by *)
contained 1 to 3 probes overlapping a variant. It is hard to predict the overall effect of these variants but, in general, those probe sets with SNPs that
have higher expression associated with the B6 allele (blue) have a higher chance of being false due to SNP artifacts. Cis modulation of expression
across tissues is most consistent for Gabra2 and Gabra1.
doi:10.1371/journal.pone.0034586.g002
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the D2 strain) [7].
We analyzed cis-regulation of expression at the level of mRNA
region using probe sets designed to target distinct transcript
regions—59 UTRs, coding exons, and 39 UTRs. Gabra2 has robust
and consistent cis-modulation across all transcript regions and
higher expression is always associated with the D allele (Figure 3). In
contrast, cis-modulation of Gabra1 and Gabrg2 expression tends to be
associated with high B allele expression but this regulation is not
congruent across all parts of the transcript. The genetic modulation
of Gabrb2 and Gabrb3 expression is even more complex. Proximal 59
features of the Gabrb2 transcript show opposite allelic regulation
compared to distal 39 features, and only one exon shows strong
genetic cis modulation for Gabrb3. Coexpression between exon
probe sets for individual subunits hints at alternative exon usage for
Gabra1 andmayprovide evidenceofmultiple isoformsofGabrb2and
Gabrb3 (Table S3) in the hippocampus.
As shown in Table 2, Gabra1, Gabrb2, and Gabrg2 are strongly
cis-modulated in both the BXD family and one other genetic cross.
Gabrb3 and Gabra2 are regulated by a strong cis eQTL in the BXD
population and two other crosses.
Downstream consequences of genetic variation on
higher order phenotypes
GABA(A)R subunits that contain strong polymorphisms control-
ling their own expression may have multiple downstream effects on
the expression of other genes or on higher order functional and
Figure 3. Summary of genetic regulation of GABA(A) R subunits across transcript features. Genetic regulation of exon, intron, and 39 UTR
features for each of the five subunits regulated by strong cis eQTLs was measured in the hippocampus using the Affymetrix exon platform (database
accession number GN206). Each probe set was required to have a mean expression of at least 10 and all probe sets overlapping SNPs were excluded.
Blue and red indicate an association between the B6 and D2 allele at each locus and higher probe set expression, respectively. The more intense hue
indicates a greater association and a corresponding increase in significance. Only Gabra2 shows strong consistency of genetic regulation across
mRNA regions.
doi:10.1371/journal.pone.0034586.g003
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location of the gene and the causal sequence variant. For example
Li, Mulligan, and colleagues used this approach to extract a large
number of phenotypes controlled by a B vs D polymorphism in
catechol-O-methyltransferase (Comt) [8]. We find that anxiety-
associated phenotypes are associated with variants near Gabrb3
(LRS.12, B allele) on Chr 7 (GeneNetwork BXD TraitIDs:11389,
11390, 11385, 11388) [9]. Despite high endogenous variation in
expression, no phenotypes map back to the locations of Gabra1,
Gabrb2, and Gabrg2 on Chr 11 or Gabra2 on Chr 5.
Trans modulation of individual subunits
We identified five subunits with hippocampal expression variation
associated with unique trans eQTLs that have LRS scores above 15
(Figure 1 and Table S2). Within each of these five trans eQTL we
nominated candidate genes that may control subunit expression
based on five criteria: (1) correlation with GABA(A)R subunit
expression in the hippocampus, (2) overlapping expression patterns
in the hippocampal formation (Allen Brain Atlas), (3) true cis
modulation of candidate regulatory genes in the hippocampus, (4)
partial correlation analysis, and (5) significant correlation in normal
aged human brain (database accession number GN314) [10]. These
criteria were selected based on previous studies, principals of QTL
mapping, and translational relevance (see methods).
Gabra1. Collectively, Gabra1 probe sets target the last coding
exon and proximal 39 UTR (1421280_at), the proximal to middle
portions of the 39 UTR (1421281_at), and the distal segment of the 39
UTR (and 1436889_at). Probe sets 1421280_at and 1421281_at are
modulated by trans eQTLs on Chr 16 at 92.79 Mb (LRS=18.4,
higher expression associated with the B allele) and 97 Mb
(LRS=17.7, higher expression associated with the B allele),
respectively. No candidates were identified near 97 Mb. The best
candidate within the trans QTL region at 92.79 Mb is Son cell
proliferation protein (Son). Two probe sets of Son (1420951_a_at and
1439074_a_at) are correlated with Gabra1 probe set 1421280_at
(r.0.39) and retain the highest partial correlation. Son is polymorphic
between B and D haplotypes and ishighly expressed in hippocampus.
In human brain, SON (201086_x_at) is highly correlated (r=0.56)
with expression of the middle and distal region of GABRA1
(244118_at) but not the last two exons and proximal 39 UTR.
Table 2. Summary of GABA(A)R subunit cis modulation among several genetic crosses.
C57BL/6J by DBA/2J
(GN110)
C57BL/6J by C3H/HeJ
(GN166)
Cast/EiJ by C57BL/6J F2
(GN171) LXS (GN133)
Gabra1 LRS 68.7 N.S. 21.38 N.S.
Allele B6 N.S. B6 N.S.
Marker rs3693664 N.S. rs3690160 N.S.
Location Chr11 @ 42.18 Mb N.S. Chr11 @ 36.83 Mb N.S.
Probe set 1436889_at* 10024407236 10023853271 ILM130372
Gabrg2 LRS 38.24 17.9 N.S. N.S.
Allele B6 C3H N.S. N.S.
Marker rs3693664 rs3703534 N.S. N.S.
Location Chr11 @42.18 Mb Chr11 @ 32.01 Mb N.S. N.S.
Probe set 1437147_at 10024394157 10023851905 ILM6550037
Gabrb2 LRS 79.6 N.S. 315.092 N.S.
Allele B6 N.S. Cast N.S.
Marker rs3693664 N.S. rs3693664 N.S.
Location Chr11 @ 42.18 Mb N.S. Chr11 @ 42.18 Mb N.S.
Probe set 1429685_at* 10024404255 10028675696** ILM100780086
Gabrb3 LRS 82.5 N.S. 27.74 123.71
Allele D2 N.S. Cast ISS
Marker gnf07.050.858 N.S. mCV23672419 rs8269265
Location Chr7 @ 63.78 Mb N.S. Chr7 @ 64.83 Mb Chr7 @ 65.05 Mb
Probe set 1421190_at 10024393218 10018192374 ILM4150164
Gabra2 LRS 33.66 92.17 442.306 N.S.
Allele D2 C3H Cast N.S.
Marker rs13478320 rs3672514 rs3681370 N.S.
Location Chr5 @ 71.13 Mb Chr5 @ 74.3 Mb Chr5 @ 70.53 Mb N.S.
Probe set 1455444_at 10024403803 10018193088 ILM3290167
Chr=Chromosome, Mb=Megabase, N/S=Not significant or suggestive. Shading=Possible SNP artifact as the probe overlaps a SNP between parental strains
(rs28224563),
*=Probes overlapping SNPs removed and mapping performed with the first principal component of the remaining probes,
**=SNP between parental strains (rs28218735) overlapping probe but the allele effect (Cast high) indicates no effect on probe binding. NOTE: ILM4150164 is
overlapping rs37397520 which is a SNP between B6 and PWK/PhJ but is probably not segregating in the LXS strains which are derived from A, AKR, BALB/c, C3H/2,
C57BL, DBA/2, IS/Bi, and RIII. However the genotype of IS/Bi and RIII is unknown and IS/Bi is now extinct. For Gabra1, a probe from probe set rs28224563 overlaps a SNP
between parental strains.
doi:10.1371/journal.pone.0034586.t002
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genes and variants that influence Gabra2 expression in the
hippocampus (LRS.15, higher expression associated with the D
allele). Within this chromosomal region there are several candidates
whose expression is strongly cis-regulated, correlated with Gabra2
expression, and that share the pattern of expression of Gabra2 in the
hippocampus. Candidates include host cell factor C2 (Hcfc2,
1438328_at, 82.20 Mb, LRS=107.6), 59 nucleotidase domain
containing 3 (Nt5dc3, 1443558_s_at, 86.24 Mb, LRS=69.189),
synapsin 3 (Syn3, 1443006_at, 85.66 Mb, LRS=25.078), and
stabilin 2 (Stab2, 1419423_at, 86.3 Mb, LRS=55.707).
Expression of Nt5dc3, Syn3,a n dHcfc2 is negatively correlated with
Gabra2 (r=20.52, 20.35, and 20.43, respectively) while Stab2
expression is positively correlated (r=0.39). Nt5dc3 and Hcfc2 have
moderate to high expression in hippocampal regions CA1 through
CA3, as well as in the dentate gyrus. Syn3 is relatively abundant in
dentate gyrus, whereas Stab2 is not abundantly expressed. The
highest partial correlation after correction was with Nt5dc3. Of the
three candidates, Hcfc2 (235264_at) has the highest correlation with
GABRA2 (1554308_s_at) expression in human brain (r=0.63).
Gabra5. Expression of Gabra5 is significantly regulated by
sequence variants on Chr 19 around 16 Mb (LRS=17, higher
expression associated with the D allele). The strongest candidate is
riboflavin kinase (Rfk, 17.4 Mb). Expression of Rfk (1415737_at)
varies 2-fold across BXD strains, is positively correlated (r=0.431)
with Gabra5 probe set expression, and is well expressed in the
hippocampus. Rfk is also highly polymorphic and expression is
associated with a strong cis eQTL (LRS.50) with ,50% higher
expression from the D allele. A ,3-fold variation between the B6
and D2 strains is also confirmed by RNA-seq. In humans,
expression of RFK (203225_s_at) is strongly correlated (r=0.56)
with GABRA5 (206456_at) expression in several brain tissues from
normal aged brain.
Gabrb2. Gabrb2 probe sets collectively target different mRNA
features. Expression of probe sets targeting the middle to distal
segment of the 39 UTR are modulated in trans by a region on Chr 8
at ,14.5 Mb. Modulation is significant for some probe sets
(1429685_at, LRS=16.3) and suggestive for others (1428205_
x_at and 1428204_at, LRS.10) and always associated with higher
expression from the D allele. The best candidate gene is kelch repeat
and BTB (POZ) domain containing 11 (Kbtbd11, 1430073_at,
15.0 Mb). Kbtbd11 is polymorphic, has high expression in the
hippocampus, and is correlated with the expression of Gabrb2
(r=0.41). The expression of Kbtbd11 is also modulated by a strong cis
eQTL (LRS=110.8, 14.48 Mb). In human brain, KBTBD11
(204301_at) expression is strongly negatively correlated with the
expression ofmultipleGABRB2probesetstargeting thelastexon and
proximal 39 UTR (207352_s_at, r=20.53) to the distal 39 UTR
(1557122_s_at, r=20.69). The function of this gene is unknown.
Gabrg1. A significant trans eQTL on Chr 14 at ,60 Mb
modulates expression of Gabrg1.C a n d i d a t eg e n e si n c l u d e ,Atp8a2
(probe set 1440627_at, mean=8.83, r=20.533, LRS=26.9 at
59.82 Mb), Ebpl (1417298_at, mean=9.99, r=0.45, LRS=26 at
61.92 Mb), and Tnfrsf19 (1448147_at and 1415921_a_at,
mean=11, r=0.45, LRS=17.3 at 59.83 Mb). In situ binding
intensityinthehippocampusislowforAtp8a2,mo de ra tefo rTnfrsf19,
and high for Ebpl. All three remain correlated with Gabrg1 after
control for linkage disequilibrium, but Atp8a2 and Tnfrsf19 retain the
highest partial correlation. All three are polymorphic between B and
D haplotypes and there is evidence of differential isoform expression
in RNA-seq data sets for both Atp8a2 and Tnfrsf19 (see
ucscbrowser.genenetwork.org). Only EBPL (223306_at) is modestly
correlated (r=0.43) with GABRG1 (241805_at) expression in human
brain, although the function of this gene is not known.
Subunit coexpression
Genetic variation results in profound and highly variable patterns
of transcript expression among individuals. We can leverage this
covariation to identify potential partnerships among subunits and
among members of larger GABA(A)R-associated expression net-
works. We examined subunit coexpression signatures from BXD
hippocampus (database accession number GN110) to detect possible
subunit combinations and joint expression of functional GABA(A)R
subtypes (Figure 4 and Table S4). As expected, subunits known to
form the major heterotrimeric receptor [11,12]—Gabra1, Gabrb2,
and Gabrg2—are generally well and positively coexpressed—higher
or lower expression of one isoform in a particular strain being
associated with matched variation of functionally associated
isoforms.
Discordant expression
A more intriguing and unexpected finding is that probe sets
representing different regions of the same subunit (e.g, last coding
exons, proximal 39 UTRs, and distal 39 UTRs) are often not
correlated and have non-overlapping sets of covariates (Figure 4
and Table S4). Gabra4, Gabrb2, Gabrb3, and Gabrg2 each have two
or more probe sets targeting different parts of the same mRNA
that are uncorrelated. These discordant probe sets have excellent
sequence specificity, are all well expressed, and have biologically
relevant expression correlates. The inconsistency can be resolved
by comparing expression patterns between similar regions of
different subunits. For example, probe sets of Gabra1, Gabrb2, and
Gabrg2 that target 39 coding exons and the proximal 39 UTR are
highly correlated, as are probe sets targeting the middle and distal
39 UTR. Within these two regions probe sets have an average
correlation of 0.50 and 0.65, respectively. Many highly correlated
(r.0.40) subunit pairs also follow this trend of coexpression within
mRNA region: Gabra2 and Gabrb1 (last coding exons and proximal
39 UTR), Gabra4 and Gabrg1 (more distal 39 UTR), Gabra4 and
Gabrg2 (more distal 39 UTR), Gabra5 and Gabrb3 (more distal 39
UTR), and Gabra4 and Gabra5 (more distal 39 UTR).
To evaluate the consistency and biological relevance of this
finding, we examined coexpression between probe sets targeting
different mRNA regions of the same subunit across brain tissues in
both mouse and human. We were able to replicate the striking
correlation between probe sets targeting different regions of the
same mRNA in whole brain and cerebellum (database accession
numbers GN123 and GN56, respectively) from the BXD family
for Gabra1, Gabra3, Gabrb1, Gabrb2, Gabrg2, and Gabrb3 (Table S5).
We were also able to replicate the complex correlation pattern
between coding exons and different regions of the 39 UTR for
Gabra5, Gabrb2, Gabrb3, and Gabrg3 in normal adult human brain
tissue (database accession number GN314) (Figure 2). This pattern
of mRNA regional covariation across probe sets in human varies
depending on cortical region.
RNA-sequencing
To explore GABA(A)R subunit coexpression networks on a more
global level, we calculated correlations based on gene-level
expression data from whole brain RNA-seq (Figure S3). This
analysis corroborates some features of the array data, including the
strong coexpression of Gabra1, Gabrb2, and Gabrg2, as well as a
strong positive correlation for most of the subunits. Subunits with
negative correlations in the RNA-seq coexpression network relative
to most other isoforms include Gabra2. Similar to the complex
correlation pattern between different mRNA regions of GABA(A)R
subunits on the M430 array, we also seestrong negative correlations
between each predicted isoform of Gabrb3 and Gabra6.
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and impact on phenotype
Are sets of different subunits and their coexpression networks in
the hippocampus controlled jointly by common trans eQTLs? We
identified three unlinked regions, all on Chr 5 with peaks at ,90–
92 Mb, 117–120 Mb, and 137–138 Mb (Figure S4) that modulate
expression of multiple subunits. The most proximal region of Chr 5
controls expression of the last coding exon and the proximal and
middle part of the 39 UTR of Gabrb3 and the distal 39 UTR of
Gabra5. The middle QTL controls the expression of middle to distal
parts of the 39 UTR of four subunits—Gabra1, Gabrb2, Gabrb3,a n d
Gabrg2. The last QTL modulates the expression of the last coding
exon and the proximal 39 UTR of six subunits—Gabra1, Gabra2,
Gabra3, Gabrb2, Gabrb3,a n dGabrg2. The last coding exons and
proximal 39 UTR of four of these subunits (Gabra1, Gabrb2, Gabrb3,
and Gabrg2) are jointly—albeit unequally—regulated by the middle
and distal Chr 5 loci (Figure S4). Higher expression is associated
with the D allele at these three loci with the exception of the distal 39
UTR of Gabra5 and Gabrb3, and the middle 39 UTR of Gabrg1.W e
identified candidate genes in each interval that may regulate the
network covariation based on criteria described previously: (1)
correlation with GABA(A)R subunit expression in the hippocampus
(accession number GN110), (2) overlapping expression patterns in
the hippocampal formation (Allen Brain Atlas), (3) true cis
modulation of candidate regulatory genes in the hippocampus, (4)
partial correlation analysis.
N The proximal QTL contains three candidate genes modulated
by strong cis eQTLs—Anxa3 (1460330_at, 97.3 Mb,
LRS=43.8), Naaa (1452067_at, 92.7 Mb, LRS=87.5), and
Cox18 (1415710_at, 90.64 Mb, LRS=148.8). The B allele at
this locus is associated with increased expression of Anxa3 and
Naaa and the D allele is associated with higher expression of
Cox18. Only Naaa has moderate to high in situ labeling in the
hippocampus. Gabra5 expression is correlated with Anxa3
(r=0.43), Naaa (r=0.58), and Cox18 (r=20.26). Expression of
the Gabrb3 probe set representing the middle portion of the 39
UTR is also correlated with Anxa3 (r= 20.31), Naaa
(r=20.27), and Cox18 (r=0.44). The highest partial correla-
Figure 4. Coexpression of GABA(A) Receptor subunits in the hippocampus. Bold lines indicate a correlation between 1 and 0.7 while
normal and dashed lines indicate a correlation between 0.7 and 0.5 and 0.5 and 0.3, respectively. Warm colors represent positive correlations while
cool colors represent negative correlations. Probes containing SNPs were removed and a principal component analysis (PCA) was used on the
remaining probes to capture the component explaining the majority of the expression variation (PC1) in probe expression among BXD strains. PCA
was used to extract PC1 for a single subunit when more than two probe sets were strongly correlated (r.0.8) and the average (AVG) was used when
two probe sets were strongly correlated. prox=proximal, mid=middle. The highest positive correlations are between subunits targeting the same
mRNA region. This is especially true for members of the most common heterotrimeric receptor—Gabra1, Gabrb2, and Gabrg2.
doi:10.1371/journal.pone.0034586.g004
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both Gabra5 and Gabrb3.
N The middle QTL contains three genes controlled by strong cis
eQTLs—Nos1 (1438483_at, LRS=31.1 at 118.33 Mb), Rasal1
(1458643_at, LRS=31.7 at 119.76 Mb), and Thrap2
(1434602_at, LRS=100 at 118.40 Mb). Probe sets for each
candidate are correlated (|r|.0.3) with multiple GABA(A)R
probe sets. Intensity of in situ label in hippocampus is high for all
three.
N The distal QTL, identified previously as Trans5a, modulates the
expression of multiple subunits and also regulates the expression
of hundreds of other transcripts in the hippocampus [13].
Overall and colleagues nominated Zkscan1 as a candidate trans
regulatory gene in this region. We re-examined Trans5a with
specific reference to GABA(A)R subunits. This region contains
three genes associated with strong cis eQTLs that contain
multiple sequence polymorphisms and are involved in tran-
scriptional processes—Taf6, Zipro1, and Zkscan1.B o t hTaf6 and
Zkscan1 are abundantly expressed in the hippocampal formation
but Taf6 is not as well correlated with subunit expression. Both
Zipro and Zkscan1 are correlated(|r|.0.5) with the expression of
one or more GABA(A)R subunits but Zipro1 expression is most
correlated with Gabrg1 expression, only. In contrast, Zkscan1
(1447944_at) expression is highly correlated (r.0.5) with that of
multiple subunits (last exon and proximal 39 UTR probe sets of
Gabrb3, Gabrg2, Gabra1,a n dGabrb2). Zkscan1 probe set
1447944_at also retained the highest partial correlation with
GABA(A)R subunits, indicating a residual biological signature
that preserves the structure of the network.
Gene variants within the middle and distal regions (118–120.5 Mb,
and 137–138 Mb) modulate the expression of multiple GABA(A)R
subunits and have a large impact on the expression of synaptic genes
in the hippocampus. Variation within this region would be expected to
have downstream effects on biological function. Multiple phenotypes
are modestly to highly associated with genetic variation on Chr 5
including, doublecortin staining in the hippocampus (a measure of
adult neurogenesis), behavioral response to cocaine injection,
locomotor response to paraoxon injection, climbing scores after
methamphetamine injection,locomotorresponseaftersaline injection,
and multiple anxiety measures (Table S6).
Conserved coexpression in mice and humans
A survey in GeneNetwork across human and mouse data sets
generated using different tissues and array platforms (see methods)
identified a novel subset of genes that covary (r.0.30) with six or
more GABA(A)R subunits. These include Gucy1a3 and Gucy1b3
(Table S7) that interact functionally to form a soluble guanylate
cyclase heterodimer involved in GDP/GTP balance and nitric
oxide-mediated signal transduction [14]. Another example is
platelet-activating factor acetylhydrolase 1B sububit alpha (Pa-
fah1b1). Also known as Lis1, this gene is a key regulator of neuronal
signal transduction and the cytoskeleton, specifically through the
rho GTPase Cdc42 (Table S8) [15].
To extend the family of novel and conserved genes associated
with GABA(A) receptor networks we mined a massive (1,000
samples) and well integrated data set including human and mouse
brain tissue from various individuals and expression platforms
[16]. Subunits that comprise the major heterotrimeric receptor
subtype—Gabra1, Gabrb2, and Gabrg2—are consistently and highly
coexpressed compared to other subunits. The conserved set of
correlates for these subunits includes Syt1, Mapk9, Rgs4, and Sh3gl2
(Figure 5A). Strikingly, the core conserved module members from
Miller and colleagues [16] also have highly correlated expression
in the hippocampus of the BXD family (database accession
number GN110) and are regulated by the Trans5A locus (Chr 5 at
,133 to 140 Mb) (Figure 5B). We used WebGestalt [17] to
evaluate whether module members are enriched for specific
functions. This gene set is enriched (adjusted P,0.05) for signal
transduction (Hivep2, Atp2a2, Gabrg2, Rgs4, Plcb1, Socs5, Fgf12,
Mapk9, Glrb), synaptic transmission (Atp2b2, Glrb, Syt1, Gabrg2),
ribonucleic biosynthetic process (Atp2b2, Prps2, Atp2a2), proteolysis
involved in cellular catabolic process (Socs5, Tceb1, Cul3, Trim37),
and the synapse (Glrb, Syt1, Gabrg2).
Discussion
Expression variation and local modulation of subunit
expression
Many GABA(A)R subunits, including, Gabra1, Gabra2, Gabra5,
Gabrb2, Gabrb3, and Gabrg2, have remarkably high levels of
variation in expression among both inbred strains of mice and
normal human populations [1]. Sources of variation include
genetic, environmental/epigenetic, and technical factors. We have
controlled for several major technical sources of variation,
including hybridization artifacts generated by SNPs and small
insertions and deletions [4]. Environmental variation within
colonies of laboratory mice is modest. After the reduction of
many non-genetic sources of variance, there are still large
differences that are clearly due to downstream effects of sequence
variants—either cis effects in or near GABA(A)R genes, or trans
effects mediated by distant variants and gene loci.
Compared to genetic modulation of expression by trans eQTLs,
modulation by cis eQTLs is generally much stronger and more
consistent across platforms, tissues, and mRNA regions. In general
recombination that occurs within a gene is exceedingly rare and
most genes and gene clusters are inherited as a block from either
the B6 or D2 parent. Highly consistent expression would then be
expected across mRNA region and tissues when a single mRNA
product is produced from a single gene loci inherited in this
fashion. For example, most regions of Gabra2 mRNA are
consistently cis modulated with low expression associated with
the B allele regardless of platform, tissue, or cross (Figure 1,
Figure 2, and Figure 3). Remarkably, the widely used C57BL/6J
parent strain expresses by far the lowest level of Gabra2 mRNA
among 99 inbred strains we have studied [13]. This locus is largely
identical by descent among the parental strains and the only B vs.
D sequence variants near Gabra2—eight small indels and nine
SNPs—fall within introns or intergenic regions (ucscbrowser.gen-
enetwork.org). One or more of these local variants contribute to a
2-to 3-fold difference in Gabra2 expression.
In contrast and contrary to our expectations, cis modulation of
other subunits is not consistent across platforms, tissues, and
mRNA/probe set target regions (Figure 1, Figure 2, Figure 3, and
Table S3) even though these genes and gene clusters are inherited
as a single haplotype block. Determining the source of this
discordance is inherently complex. For example, the B allele of
Gabra1 has high expression in most array data sets, a finding that
we cannot validate using either allele-specific expression assays or
RNA-seq. In the case of Gabrg2, Gabrb2, and Gabrb3, alleles with
higher expression are dependent on tissue, platform, and mRNA
target region. A parsimonious explanation is the expression of a
diverse repertoire of isoforms—a finding that is supported by the
existence of alternative isoforms for many of the cis modulated
subunits, including Gabrb2 and Gabrg2 [18,19]. Hundreds of B vs.
D polymorphisms in Gabra1, Gabrb2, Gabrb3, and Gabrg2 may
modulate isoform usage and expression among strains, highlight-
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impact.
Distant modulation of GABA(A)R subunits and genetic
independence
Trans eQTLs are responsible for a significant level of genetic
variation in subunits, even when expression is also under the
control of a strong cis eQTL (Figure 1 and Table S2). For example,
many of the cis-regulated subunits—Gabra1, Gabra2, Gabrb2, and
Gabrb3—are co-controlled by one or more trans eQTLs. In
addition, subunits without strong cis-modulation such as Gabrg1
and Gabra5, are strongly modulated by at least one trans eQTL.
Despite substantial coexpression among these subunits—espe-
cially for those comprising the major receptor subtype (Gabra1,
Gabrb2, and Gabrg2)—individual subunits do not control the
expression of other subunits either directly or indirectly (Figure 1).
Due to the complex evolutionary history of vertebrate genomes,
most GABA(A)R subunit genes are organized into clusters. In
mouse, the major clusters reside on Chrs 5, 7, 11, and X. Each
contains a single c, one or two a, and a single b subunit. We
expected evidence of receptor-to-receptor genetic co-modulation
in the form of trans eQTLs with locations corresponding to the
GABA(A) gene clusters. Remarkably, sequence variants and strong
cis eQTLS within each cluster do not influence the expression of
subunits in other clusters. While we do see strong cis eQTLs in
some of these clusters there is no evidence of genetic ‘‘cross-talk’’
among clusters. All trans eQTLS were located in regions of the
genome that do not contain any GABA(A)R genes (Figure 2). We
also rarely observe a high level of coexpression (r.0.6) between
GABA(A)R subunits and genes known to be involved in receptor
trafficking, such as gephyrin, GABARAP, Bdnf, neurexin, neuroli-
gin, protein kinase A and C, Trak1, and others (Table S9).
Figure 5. Conserved members of the GABA(A)R gene network. (A) Gabra1, Gabrb2, and Gabrg3 are generally well coexpressed across species
and platforms. The set of highly conserved correlates include many synaptic genes such as Syt1 and Sh3gl2. Bold lines indicate a correlation between
1 and 0.7 while normal and dashed lines indicate a correlation between 0.7 and 0.5 and 0.5 and 0.3, respectively. Warm colors represent positive
correlations while cool colors represent negative correlations. (B) Expression of conserved module members is regulated by Trans5a. LRS score and
additive effect are shown on the Y axis in blue and green, respectively. The blue line plots the strength of the association between gene expression
and chromosomal location. The genome wide significant and suggestive threshold is shown by the red and grey horizontal line, respectively. Red and
green lines show the effect of the D or B allele on trait values, respectively. The upper X-axis shows location by chromosome and the lower X-axis
shows location in megabases.
doi:10.1371/journal.pone.0034586.g005
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subunit expression. Our findings demonstrate that there is a small
set of novel and still undefined genes that modulate GABA(A)R
expression.
Novel candidate QTLs and gene variants modulate
subunit expression
Rfk, Son, and Kbtbd11 are the three best candidate genes
modulating Gabra5, Gabra1,a n dGabrb2 expression in the BXD
hippocampus, respectively. Rfk is a TNF-receptor-1 and p22 (phox)
binding protein that mediates NADPH oxidase activation and
reactive oxygen species signaling [20]. Son is thought to be involved
in mRNA processing [21,22,23]. Although, highly correlated with
the expression of Gabrb2 probe sets in both mouse and humans, the
function of Kbtbd11 is unknown. Gabrg1 has three good candidate
genes—Atp8a2, Ebpl,a n dTnfrsf19. Atp8a2and Tnfrsf19 play a role in
lipid transport across membranes and signaling pathways associated
with myelination and axon regeneration, respectively [24,25].
Mutations in ATP8A2 have been associated with mental retardation
[26]. The functions of Ebpl are unknown. Finally, Gabra2 is
modulated by a trans eQTL on chromosome 10 at ,86 Mb that
aligns precisely with a QTL that controls variation in reversal
learning among BXD strains [27]. Laughlin and colleagues
nominated Hcfc2, Syn3 and Nt5dc3 as strong candidates but Hcfc2,
a gene with unknown functions, has the highest correlation with a2
expression in mouse and human.
Master QTLs that modulate expression of multiple
subunits
Several loci are trans eQTLs for multiple subunits. In mouse
hippocampus (database accession number GN110) three unlinked
loci on Chr 5 modulate expression of nine subunits including
Gabra1, Gabra2, Gabra5, Gabra3, Gabrb1, Gabrb2, Gabrb3, Gabrg1, and
Gabrg2 (Figure S4). The most proximal QTL modulates Gabra5 and
the last coding exon and proximal to middle 39 UTR of Gabrb3.
Naaa and Cox18, genes involved in endocannabinoid metabolism
[28,29] and cytochrome c oxidase assembly [30] respectively, are
excellent candidates. COX18 (227442_at) expression is correlated
with expression of the middle 39 UTR of GABRA5 (206456_at,
r=0.41) and the distal 39 UTR of GABRB3 (227690_at, r=0.42).
Although COX18 is thought to be involved in assembly of
mitochondrial respiratory chain complexes, it may also be involved
in other undiscovered biological processes. In normal human brain
(database accession number GN314), NAAA (215178_x_at)
expression is highly correlated with both GABRA5 (215531_s_at,
20.62) and GABRB3 (227690_at, 20.62). NAAA, along with
FAAH, is involved in the degradation of N-acylethanolamines—
endogenous endocannabinoids that include the cannabinoid
receptor type 1 (CB1) agonist anandamide [31]. Many GABAergic
neurons and synapses express CB1 receptors [32,33]. Endocanna-
binoids can modulate GABAergic neurotransmission, through both
CB1 receptor-dependent [34,35] and -independent mechanisms
[36]. FAAH is generally considered to be the major enzyme
responsible for endocannabinoid degradation—especially ananda-
mide—in brain [37] but our data suggest a novel role for NAAA at
GABAergic synapses.
The middle QTL on Chr5 modulates expression of the middleto
distal parts of the 39 UTRs of four subunits—Gabra1, Gabrb1,
Gabrb2, and Gabrg2. Numerous complex traits map to this part of
Chr 5, which has been identified previously as a QTL for adult
hippocampal neurogenesis and morphology of the infrapyramidal
mossy fiber tract [38]. Three strong candidates in this region are
involved in cell signaling (Nos1 and Rasal1) [39] and transcriptional
regulation (Thrap2 or Med13l) [40,41]. Krebs and colleagues also
nominated Nos1 based on previous associations between Nos1
expression and neurogenesis and morphological variation. In
human brain (database accession number GN314), multiple NOS1
probe sets targeting different mRNA regions (239132_at,
207309_at, 207310_s_at, and 1560974_s_at) exhibit negative and
positive correlations (|r|.0.4) with the expression of multiple
GABRA1 (244118_at), GABRB1 (207010_at), GABRB2
(1557122_s_at and 207352_s_at), and GABRG2 (1568612_at) probe
sets targeting mainly the middle to distal 39 UTR. Much research
has linked nitric oxide synthase activity with GABA levels and
GABAergic neuronal subpopulations in hippocampus and other
regions [42,43,44,45]. However, the same positive or negative
correlation structure (|r|.0.46) is observed for MED13L probe sets
(212207_at, 212209_at, 242911_at) with the exception of the
GABRB1 probe set which is less well correlated (r=20.35). In
addition, MED13L is a RNA polymerase II transcriptional
coactivator and could be involved in the regulation of subunit
expression. In contrast, the expression of RASAL1 (219752_at) is
strongly and negatively correlated (r.20.5) with GABRB2
(242344_at and 1557122_s_at) only.
he distal QTL on Chr 5 identified by Overall and colleagues is a
major trans regulatory locus in the hippocampus (Trans5a) that
controls the expression of multiple GABA(A)R subunits and
hundreds of other transcripts. Both our study and that of Overall
and colleagues highlights Zkscan1 as an excellent candidate gene.
Multiple probesets target different regions of Zkscan1 mRNA. Probe
set1447944_at measuresexpression fromtheproximal39UTRand
is controlled by a strong cis eQTL. This probe set varies significantly
among BXD strains (2.45-fold) and is highly correlated (r.0.6) with
the expression of multiple GABA(A)R subunits including, Gabra1,
Gabrb2, Gabrb3, and Gabrg2. Several insertions and deletions within
Zkscan1 and just upstream of the 59 UTR could account for the
enormous variation in expression among strains. In human brain
(database accession number GN314), ZKSCAN1 (214670_at and
1557953_at) is highly correlated (r.|0.5|) with GABRA1
(244118_at), GABRA2 (207014_at and 1554308_s_at), GABRG1
(1552943_at), and GABRG2 (1568612_at) and modestly correlated
(|r|.0.35) with GABRB2 (207352_s_at) and GABRB3 (227690_at
and 229724_at). Almost nothing is known about the function of
Zkscan1 but our data implicate this gene as a high priority target for
functional validation.
In summary, we have identified strong candidate genes that
modify the expression of one or more GABA(A)R subunits. We
often observe differential genetic control corresponding to different
mRNA regions of the same subunit. In general, correlations
between candidate genes and GABA(A)R subunits are preserved
across species. Identifying the causal gene in trans regulatory regions
is likely to be more important for understandingGABA(A)R subunit
regulation than identifying specific causal variants underlying a cis
eQTL. This is because molecular networks will be much better
conserved between species than specific sequence polymorphisms.
Prevalence of 39 UTR isoforms
The Affymetrix M430 array is unusual in that the designer, Dr.
David Kulp, intentionally selected multiple probe sets to target
both proximal and distal regions of the 39 UTR. This design is
ideal for comparative analysis of UTR variants that are associated
with major differences in mRNA trafficking [46] and higher order
function [8]. CNS transcripts have unusually long 39 UTRs and
tend to utilize alternative and more distal polyadenylation sites
[47,48]. For example, the 39 UTR of Gabrb2 is nearly 6 Kb long—
4 times longer than the protein coding sequence. We also see
multiple consensus sites for polyadenylation, and evidence of
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Gabrg2 in our whole brain RNA-seq data (Figure S5, S6, S7).
An intriguing trend emerges from our dissection of GABA(A)R
subunit expression in which probe sets targeting similar mRNA
regions of different subunits are well correlated (Figure 4 and
Table S4). This is especially true for the major receptor subtype—
Gabra1, Gabrb2, and Gabrg2. Poor or negative correlations between
probe sets representing different mRNA regions of the same
subunit and high positive correlations between probe sets from
different subunits that target similar regions are replicated across
brain tissues from BXD strains as well as across human brain
samples (database accession number GN314) (Table S5 and Figure
S2). We asked if these coexpression patterns were part of a more
general transcriptional network in the hippocampus of BXD
strains (database accession number GN110). Probe sets targeting
more distal 39 UTR regions generally have higher correlations with
other probe sets targeting distal regions whereas probe sets targeting
the last few coding exons and proximal 39 UTR generally have
higher correlations with other probe sets targeting these proximal
regions (Table S9). This pattern of coexpression—short to short,
and long to long—may be related to differences in mRNA
processing based on 39 UTR length. Variation at the 39 end of
mRNA can expose alternate miRNA and protein binding sites that
change localization, stability, or translation efficiency (reviewed in
[49]). Another intriguing possibility that could explain the
discordant expression between 39 UTR and coding regions is the
expression ofdistinct RNAtranscriptsfrom withinthe39 UTR [50].
Mercer and colleagues mined RIKEN CAGE data to identify genes
producing full-length transcripts from the 39 UTR, including
Gabra1, Gabra6, Gabra3,a n dGabrb2 (mouse) and GABRA2, GABRB1,
and GABRB2 (human). Within this gene category and in 54% of the
cases, expression of the 39 UTR and coding exon is discordant.
Further molecular analysis of 39 UTR expression and new high-
throughput methods for quantifying the 39 end of mRNA will be
needed to resolve which mechanisms contribute to the divergent
expression patterns we observe among GABA(A)R subunit mRNA
regions. How these isoforms contribute to cell and synapse type,
circuitry, and disease will be a critical aspect of future studies.
Functional impact of subunit variation and relevance to
human disease
There is a lack of association between cis modulated GABA(A)R
subunits and classic phenotypes generally linked with GABAergic
signaling, including alcohol-related, anxiety, and pharmacological
measures. Of course not every trait associated with these receptors
has been measured among BXD strains and several physiological
phenotypes, including receptor density and neuronal excitabilityare
notable absent. However, the lack of association withavailable traits
is still surprising given that as little as a 6 to 35% reduction in
receptor density can produce robust phenotypic differences [51,52].
The sole exception is for b3, a subunit that is genetically linked to
mousebehaviorsassociated with anxiety.Deletion ofGabrb3 leadsto
an increase in stretch-attend posturing—an phenotype associated
with risk assessment [53]. Deletions of the 15q11-13 region in
humans—including GABRB3—are associated with Angelman
syndrome and severe cognitive deficits, a constellation of pheno-
types matched in Gabrb3-deficient mice [54,55].
The variation level of many GABA(A)R subunits is very high
among individual strains and yet the functional impact on classic
phenotypes—behavior and neuropharmacological traits, in partic-
ular—is minimal. In a normal human population we observe even
greaterdifferencesinexpressionofthesesubunits—upto100-foldin
adults. Individual humans are highly polymorphic and a small
portion of this variation could result from platform-dependent
artifacts caused by hidden variants. However, whole genome and
transcriptome sequencing technologies are rapidly advancing and
our findings suggest that a high level of expression variation will
persistevenafterthesetypesoftechnicalerrorsarecorrected. Thisis
an important negative finding that demonstrates the impressive
ability of higher order network properties to buffer the variation of
their constitutes. Much of this buffering may occur during
translational processing and a 10-fold difference in transcript may
be muted at the protein level. How molecular networks buffer,
exploit, or accommodate high levels of variation in transcript
expression is a major question that has not yet been addressed.
Why study variation in expression that does not cause prominent
differences in phenotype? It is rare to find a natural variant that
produces a null or fully penetrant phenotype. The subtle push and
pull of modest gene variants on expression is a natural perturbation
that exposes the large-scale structure of networks of genes and
molecules. Understanding network structure and relations is highly
relevant for understanding complex traits and disease risk. We
identified members of the GABA(A)R network that are conserved
across rodents and humans (Figure 5). These members are involved
in signal transduction (Rgs4, Mapk9, Socs5) and synaptic transmission
(Syt1) and are likely to be important for the function of GABAergic
synapses. In the hippocampus, this network is under genetic control
and expression is strongly modulated by the Trans5a QTL.
Wealsoexaminedthesetofconservedexpressioncorrelatesoffive
or more GABA(A)R subunits and identified genes with the highest
correlation levels in both human and mouse brain. These genes are
likely to be important for subunit expression at GABAergic synapses
and include, Lis1, Gucy1a3 and Gucy1b3 (Table S7, Table S8). Lis1 is
strongly associated with expression of many subunits in both species
and is a member of the conserved GABA(A)R network. During
development Lis1—along with GABA and other signaling mole-
cules—is a key mediator of neuronal migration [56,57]. Knockout
mice have cortical and hippocampal defects and heterozygotes
exhibit alterations in CA1 inhibitory circuits implicating dysfunction
of the GABAergic system [58,59]. GUCY1A3 (a1) and GUCY1B3
(b1) are subunits of soluble guanylyl cyclase, the main receptor for
the retrograde signaling molecule nitric oxide (NO). NO can
enhance GABAergic signaling through activation of presynaptic
guanylyl cyclase and production of cGMP [60,61,62,63].
Conclusion
Our comprehensive analysis highlights the way in which
expression variation and covariation can be used to identify strong
candidates and novel biological processes that play a critical role in
GABA(A)R mediated inhibitory transmission. We now have ample
evidence of profound alternative 39 UTR expression for many
subunits in human and mouse brain. Elucidating the molecular
regulation and functional consequences of theseexpression patterns is
of the utmost importance. We also have identified a large and
surprising list of regulatory genes and network members that are
highlycorrelated with subunit expression in human and mouse brain.
Most of these candidates are novel and suggest new and interesting
modes of organization that influence GABA(A)R expression in brain.
Materials and Methods
Ethics Statement
All animal work was conducted according to an approved
animal use protocol (UTHSC680) and in accordance with
procedures approved by the Executive Committee of the
Institutional Animal Care and Use Committee at The University
of Tennessee Health Science Center.
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Detailed information and free access to all human and mouse
data is provided at www.genenetwork.org. Mouse brain data sets
include ‘‘Hippocampus Consortium M430v2 (Jun06) RMA’’
(accession number GN110). This data set incorporates expression
profiles from 67 BXD RI strains, B6 and D2 parental strains and
reciprocal F1 hybrid strains, and 15 inbred strains (mouse diversity
panel). The ‘‘UMUTAffy Hippocampus Exon (Feb09) RMA’’
(accession number GN206) data set includes expression profiles
from 72 BXD strains, B6 and D2 parental strains, and reciprocal F1
hybrid strains. The ‘‘Hippocampus Illumina (May07) RankInv’’
(accession number GN133) data set includes expression profiles
from parental strains, ILS/Ibg (Inbred Long Sleep) and ISS/Ibg
(Inbred Short Sleep), and 75 of their inbred progeny (LXS strains),
and reciprocal F1 strains. The ‘‘OX UK HS ILM6v1.1 Hippo-
campus (May 2010) RankInv’’ (accession number GN268) data set
includes expression profiles from 465 heterogeneous stock mice
[64]. Data from other crosses include brain expression data
measured on the Agilent platform among an F2 intercross between
CAST/EiJ and C57BL/6J (accession number GN171) and among
an F2 intercross between C57BL/6J and C3H/HeJ (accession
number GN166). Other data sets include expression profiling on
various microarray platforms among the BXD family of strains in
the cerebellum (accession number GN56), whole brain (accession
number GN123) [65], striatum (accession number GN298),
neocortex (accession number GN282), amygdala (accession number
GN280), and hypothalamus (accession number GN281).
Briefly, human brain tissue data sets include, ‘‘GSE5281 Human
BrainNormalFullLiang(Jul09) RMA’’(accession numberGN314),
‘‘GSE15222 Human Brain Normal Meyers (Apr09) RankInv’’
(accession number GN234), and Harvard Brain Tissue Resource
Center ‘‘HBTRC-MLC Human Cerebellum Agilent Normal
(Jun11) mlratio’’ (accession number GN361). For data set GN314,
cases include 16 normal aged subjects [10,66], and gene expression
was profiled for six regions on the Affymetrix platform. For data set
GN234, expression was profiled for temporal cortex and cortical
tissue from 187 normal aged adults on the Illumina Sentrix Bead
array (HumanRef-8) using Illumina’s rank invariant transform [67].
Data set GN361 includes expression profiles for cerebellum, visual
cortex, and prefrontal cortex from 170 normal subjects using a
custom-made Agilent 44 K microarray. Only expression in the
cerebellum was used for comparison of rodent and human
coexpression. This data set was contributed by Merck Pharmaceu-
tical through the Sage Bionetworks Repository.
Removal of probe sets overlapping B6 and D2 sequence
variants
All 19 known GABA(A) subunit genes are represented by at least
one probe set on the Affymetrix M430 2.0 and Exon 1.0 ST
platforms. The former is designed to produce consensus estimates of
expression across multiple mRNA isoforms using probes that target
the 39 UTR and the last few coding exons. In contrast, the exon
array is designed to target every exon. Illumina probes generally
target a single region from the last coding exons or the 39 UTR.
Probe target sequences corresponding to GABA(A) probe sets for
Illumina and exon hippocampus BXD data sets were matched to all
B6 and D2 SNPs and small indels. The offending probe set was
removed every time an overlap occurred. For the M430 data we
filtered out probes overlapping polymorphisms using tools in
GeneNetwork. We used the remaining probe values and principal
component analysis to construct corrected probe set values from the
first principal component (PC1). B6 vs. D2 sequence variants were
generated at UTHSC by comparison of the B6 reference genome
and the D2 genome (1006whole genome coverage). This level of
coverage was achieved using data generated from both the SOLiD
and Illumina sequencing platforms and exceeds that of any other
publicly available variant database. Variant data can be visualized
by gene at ucscbrowser.genenetwork.org or by probe set using the
RNA-seq tool in GeneNetwork. A list of all affected and unaffected
probe sets is available in Table S1.
Heritability
We calculated the broad-sense heritability to estimate the
influence of genetic factors on variation in GABA(A)R subunit
expression for the Hippocampus M430 data set. Heritability is the
genetic variance (variance among strain means) divided by the
total variance (variance among all measurements).
RNAseq Analysis
TotalRNA wasisolatedfromthe wholebrainof B6,D2,31BXD,
and two reciprocal F1 hybrid strains using the QIAGEN RNeasy kit.
RNA quality was assessed using the Agilent Bioanalyzer 2100.
Ribosomal RNA (rRNA) was removed from total RNA using the
RiboMinus Eukaryote kit (Invitrogen). The SOLiD Whole Tran-
scriptome Analysis kit was used to generate cDNA libraries for each
strain. Each library was subsequently sequenced on the ABI SOLiD
platformattheUniversityofTennesseeHealthScienceCenter.Data
was analyzed using Applied Biosystems whole transcriptome
software tools (http://www.solidsoftwaretools.com/). Reads are
mapped to the mouse reference genome (mm9, National Center
for Biotechnology Information (NCBI) build 37) with a minimum
score of 24. Technical replicates were merged for each strain to
produce a single BAM file (data available in our mirror of Galaxy at
GeneNetwork, galaxy.genenetwork.org/library). The Cufflinks tool
[68] was used within the Galaxy framework [69,70] to generate gene
level expression data based on RefSeq gene models (build 37) using a
maximum intron length of 300,000, minimum isoform fraction of
0.1, and pre-mRNA fraction of 0.15.
Identification of Candidate Genes in Upstream
Regulatory Regions
Genes physically located within trans regulatory regions were
filtered based on cis-modulation, coexpression within the tissue of
interest, and covariation with the target GABA(A) subunit.
Expressioninthehippocampuswasconfirmed foreach candidate
using the Allen Brain Atlas resource. Any candidate gene probe sets
overlapping SNPs that also showed significantly higher expression
associated with the B Allele were removed (see Ciobanu and
colleagues 2010 for details). Candidates not polymorphic between
B6 and D2 were also removed. Overlapping expression of the
control and target gene in the tissue of interest and the presence of
polymorphisms in the control gene locus are required conditions of
nearly all cis-trans interactions as both genes can act within the same
biological process or pathway [71]. If a candidate gene did not
demonstrate highly significant cis-regulation (LRS.15) or covari-
ation (r.|0.3|) with the target gene it was excluded from further
analysis. Correlational analysis has also proven to be a useful tool to
narrow the list of candidate genes [4,72].
In general, multiple candidates were identified within each trans
regulatory region using the above approach. Linkage between
genes in close proximity can make it difficult to further narrow the
list of candidate genes. To facilitate candidate gene identification
we used the partial correlation feature available in GeneNetwork
to determine the most likely set of cis-modulated genes within
upstream regulatory regions that control target GABA(A) subunit
expression. A partial correlation is the degree of association
between a primary variable and a target variable after removing
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partial correlations have been described in detail elsewhere [74].
In this case, the correlation between GABA(A)R subunit probe set
expression (primary variable) and the expression of candidate
regulatory gene probe sets (target variables) was measured after
controlling for genetic variation at the peak trans QTL marker. We
reasoned that, in the absence of genetic variation, residual
biological variation would retain the correlation between the
expression of the GABA(A)R subunit and the candidate regulatory
gene. Therefore the candidate regulatory gene with the lowest
reduction in the correlation between itself and GABA(A)R subunit
expression is a superior candidate. Finally, covariation of the
candidate control gene and the target subunit were examined in
normal aged human brain samples (database accession number
GN314) [10]. Correlations between control and target genes that
are preserved across species are more likely to represent real
biological networks of high translational relevance and were used
to further prioritize candidate genes.
Exon Coexpression
The ‘‘UMUTAffy Hippocampus Exon (Feb09) RMA’’ (accession
number GN206) data set was used to investigate coexpression
between expressed exons and introns for individual GABA(A)R
subunits. As described previously, probe sets overlapping SNPs were
removed and only those probe sets with an average log2 expression of
10 or greater were included in the analysis. Pair-wise Pearson and
Spearman correlation coefficients were calculated among probe sets
for each subunit using tools available in GeneNetwork. The
correlation structure between probe sets was used as an indirect
method to identify possible instances of alternative splicing—observed
as a lack of correlation between probe sets targeting different exons of
the same subunit. Probe sets from this array do not target exon-exon
junctions and do not provide a direct measure of splicing.
Cross-Species Coexpression
Modules (usually identified by a color) containing GABA(A) R
subunits were identified from a weighted gene coexpression
analysis of human and mouse data sets [16]. Most GABA(A)
subunits had the highest correlation with the black and red module
eigengenes in human and the tan module eigengene in mouse.
Correlation with these three module eigengenes (R.0.3) was used
to define coexpressed genes, including the GABA(A) subunits
(GABRA1, GABRB2, GABRG2, and GABRB3). Overlap be-
tween the human and mouse module membership was determined
by gene symbol. The expression of this consensus module of 28
genes was explored using the Hippocampus M430 database. A
single probe set was selected for each gene based on correlation
within the module. The first principal component captured ,55%
of the expression variation of module members and was used for
QTL mapping. Genes from the human and mouse modules
(r.0.3) were also compared to the results of a limited GeneNet-
work cross-species survey to assess the amount of connectivity with
other GABA(A) R subunits.
The criterion for consistent cross-species association was defined
as: r$|0.3| for three human (GN314, GN234, GN361) and three
mouse brain data sets (GN110, GN133, GN268). Because of the
number of samples within each database, this correlation is often
highly significant (p,0.001).
Supporting Information
Figure S1 Pairwise comparison of platform expression
for GABA(A)R subunits. Scatter plots were constructed for the
expression data from each platform shown in Table 1. All probe sets
were used for this analysis. Pairwise correlations based on Pearson’s r
are shown at the top left-hand corner of each scatter plot. M430
(accession number GN110), exon (accession number GN206), and in
situ data (Allen Brain Atlas Resource) are from the hippocampus
while RNA-seq data is from whole brain. There is good agreement
for theexpression of mostsubunits asassayed across platforms. More
modest correlations (,0.5) are generally associated with compari-
sons between different tissue types—whole brain and hippocampus.
(TIF)
Figure S2 Summary of GABA(A)R subunit coexpression
in human brain. Pairwise correlations based on Pearson’s r are
shown for each probe setcombinationin normal adult human brain
(data available in GeneNetwork, accession number GN314). Boxes
indicate low correlations between probe sets representing different
regions of the same subunit. Positive and negative correlations are
indicated by intensity of yellow and red shading, respectively.
(TIF)
Figure S3 GABA(A)R subunit gene coexpression based on
whole brain RNA-seq. Bold lines indicate a correlation between 1
and 0.7 while normal and dashed lines indicate a correlation between
0.7 and 0.5 and 0.5 and 0.3, respectively. Warm colors represent
positive correlations while cool colors represent negative correlations.
(TIF)
Figure S4 Summary of genetic regulation of GABA(A)R
subunit expression from Chr 5. Probes that do not overlap a
SNP or small insertion or deletion represent columns and
ascending genomic location for Chr 5 represent rows. The
position of the middle and distal (Trans5a) regulatory loci on Chr 5
are indicated by arrowheads to the left of each heat map. Hue
intensity provides an indication of the strength of the association
between gene expression and genomic location. Red and blue
alleles indicate that the D or B allele increases trait values,
respectively. Arrowheads show the location of each cognate gene.
Disparate regulation of different mRNA regions associated with
middle or distal Chr 5 loci is especially evident for Gabra1, Gabrb2,
and Gabrg2. PC1=first principal component, Chr=Chromosome,
Mb=Megabase, Prox=proximal, mid=middle, dist=distal.
(TIF)
Figure S5 Summary of Gabra1 39 UTR expression as
assayed using RNA-seq. Data available at ucscbrowser.gen-
enetwork.org. Gabra1 is located on the (2) strand. Tapering of reads
from the proximal to more distal 39 UTR indicates expression of
longer and shorter 39 UTR isoforms. This is especially prevalent in
the striatum, which included only polyadenylated transcripts for
RNA-seq. Track 1 shows the chromosomal location at top followed
by gene model based on RefSeq as track 2. Larger width indicates
coding exons and smaller width indicates 39 UTR. All known
variants between the B6 and D2 genome are indicated as part of
track 3. Tracks 4 through 7 summarize the normalized (+) and (2)
strand reads for the B6 (blue) and D2 (red) parental strains in whole
brain (RiboMinus method). Tracks 8 and 9 show normalized reads
in the striatum of 10 B6 and 11 D2 mice (PolyA enrichment
method, [75]). For tracks 4 through 9 the scale to the left shows the
read number, which will be lower for whole brain since it represents
only a single RNA-seq run from one animal. Track 10 shows
previously characterized mRNA species in mouse. Track 11 shows
the degree of sequence conservation in mammals and Track 12
shows the presence of any repetitive DNA which is masked by most
RNA-seq alignment algorithms.
(TIF)
Figure S6 Summary of Gabrb2 39 UTR expression as
assayed using RNA-seq. Data available at ucscbrowser.genenet-
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reads in the 39 UTR, especially evident in the striatum, could
indicate alternative polyadenylation or splicing. Track 1 shows the
chromosomal location at top followed by gene model based on
RefSeq as track 2. Larger width indicates coding exons and smaller
width indicates 39 UTR. All known variants between the B6 and D2
genome are indicated as part of track 3. Tracks 4 through 7
summarize the normalized (+)a n d( 2) strand reads for the B6 (blue)
and D2 (red) parental strains in whole brain (RiboMinus method).
Tracks 8 and 9 show normalized reads in the striatum of 10 B6 and
11D2mice(PolyAenrichment method,[75]).Fortracks4through9
the scale to the left shows the read number, which will be lower for
whole brain since it represents only a single RNA-seq run from one
animal. Track 10 shows previously characterized mRNA species in
mouse. Track 11 shows the degree of sequence conservation in
mammals and Track 12 shows the presence of any repetitive DNA
which is masked by most RNA-seq alignment algorithms.
(TIF)
Figure S7 Summary of Gabrg2 39 UTR expression as
assayed using RNA-seq. Data available at ucscbrowser.gen-
enetwork.org. Gabrg2 is located on the (2) strand. Tapering of reads
from the proximal to more distal 39 UTR indicates expression of
longer and shorter 39 UTR isoforms. This is especially prevalent in
the striatum, which included only polyadenylated transcripts for
RNA-seq. Track 1 shows the chromosomal location at top followed
by gene model based on RefSeq as track 2. Larger width indicates
coding exons and smaller width indicates 39 UTR. All known
variants between the B6 and D2 genome are indicated as part of
track 3. Tracks 4 through 7 summarize the normalized (+)a n d( 2)
strand reads for the B6 (blue) and D2 (red) parental strains in whole
brain (RiboMinus method). Tracks 8 and 9 show normalized reads
in the striatum of 10 B6 and 11 D2 mice (PolyA enrichment
method, [75]). For tracks 4 through 9 the scale to the left shows the
read number, which will be lower for whole brain since it represents
only a single RNA-seq run from one animal. Track 10 shows
previously characterized mRNA species in mouse. Track 11 shows
the degree of sequence conservation in mammals and Track 12
shows the presence of any repetitive DNA, which is masked by most
RNA-seq alignment algorithms.
(TIF)
Table S1 Summary of GABA(A)R probe sets, expression, and
overlapping variants in the hippocampus. Chr=Chromosome,
Mb=Megabase, c=Coding, prox=proximal, dist=distal, Mean
Expr=Mean Log2 Normalized Expression, FC=Fold Change,
MRS=SNP, MINA=small insertion, Shading=Mean Expr.8
(M430) or .10 (Exon).
(XLSX)
Table S2 Summary of GABA(A)R heritability and eQTLs in the
hippocampus. Expression (Expr), standard deviation (SD), and fold
change(FC) calculated across all strains, including parents and F1.
*=probes overlapping SNPs removed and probe set reconstructed
as the first principal component (PC1). PC1 used to map
expression quantatative trait loci (eQTL). Only eQTL that have
achieved genome wide significance (,LRS.15) are shown.
(XLSX)
Table S3 Summary of GABA(A)R exon coexpression in the
hippocampus. Expression must be greater than 10 for all probe
sets and probe sets overlapping SNPs were excluded from the
analysis.
(XLSX)
Table S4 Probe set correlations in the hippocampus.
(XLSX)
Table S5 Probe set correlations in the whole brain and
cerebellum.
(XLSX)
Table S6 Phenotypes mapping to middle and distal Chr 5 QTLs.
(XLSX)
Table S7 Summary of across species correlations between
GABA(A)R subunits and Gucy1a3 and Gucy1b3.
(XLSX)
Table S8 Summary of across species correlations between
GABA(A)R subunits and Pafah1b1/Lis1.
(XLSX)
Table S9 Summary of Gabra1, Gabrb2, and Gabrg2 exon and
distal 39 UTR probe set correlates in the hippocampus.
(XLSX)
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